Home / Import refusals / AEK-7564602-4/50002/1

FDA Import Refusal AEK-7564602-4/50002/1 — BEXIMCO PHARMACEUTICALS LIMITED

BEXIMCO PHARMACEUTICALS LIMITED — FEI 3012773222

The FDA refused shipment AEK-7564602-4/50002/1 from BEXIMCO PHARMACEUTICALS LIMITED (Bangladesh) on September 23, 2025. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 23, 2025
Country
Bangladesh
Product Category
Drugs and Biologics
Product Code
61JDY08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
Charges
75

Other import refusals

  • AEK-9291931-3/20002/1 (Fri Jan 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9291931-3/10002/1 (Fri Jan 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9153923-7/10002/1 (Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-5505089-0/81/1 (Thu Jul 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 112-2734958-9/1/1 (Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources